Expired contract
Cruciform ARUK Drug Discovery Institute
Details
- Supplier(s)
- Peak Contractors
- Value
- GBP 307,000
- Duration
- 2 months
- Topic
- Building construction work
- Published
- 2 March 2016
- Source
- ContractsFinder
Tender description
The carrying out of alterations and refurbishment of labs and offices spaces on the 4th Floor of the Cruciform Building. Contract commencement is expected on 20th January 2016 and Practical Completion is expected 15th March 2016.
Timeline
- Completed: Award date5 January 2016
- Completed: Award published2 March 2016Current notice
- Completed: Contract expiry date4 March 2016
About the buyer
University College London is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.
Relevant CPV codes
- 45210000 · Building construction work
- 45453000 · Overhaul and refurbishment work
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@university-college-london.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@university-college-london.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@university-college-london.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@university-college-london.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@university-college-london.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@university-college-london.gov |
57 similar open tenders
See more open tenders related to Cruciform ARUK Drug Discovery Institute.
- Open tender
Provision of Contractor Services
- Open tender
Damp and Mould Works
Related buyers
Buyers similar to University College London.
BuyersCountValue
- 338£19.4m
- 270£317.1m
- 133£196.2m
- 124£173.5m
- 114£48.2m
- 112£11.7m
- 104£64.2m
- 101£60.1m
- 93£27.7m
- 85£83.4m
Win more public sector contracts
Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.
